{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:07:09Z","timestamp":1793315229591,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04080-z","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:33:55Z","timestamp":1763663635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCA"],"prefix":"10.1007","volume":"16","author":[{"given":"Yiqiang","family":"Da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"2","key":"4080_CR1","doi-asserted-by":"publisher","first-page":"166965","DOI":"10.1016\/j.bbadis.2023.166965","volume":"1870","author":"K Shi","year":"2024","unstructured":"Shi K, Zhou J, Li M, Yan W, Zhang J, Zhang X, Jiang L. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166965. Epub 2023 Nov 22. PMID: 38000776.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4080_CR2","doi-asserted-by":"publisher","first-page":"1604609","DOI":"10.3389\/fonc.2025.1604609","volume":"15","author":"Y Da","year":"2025","unstructured":"Da Y, Lu Z, Zhu Z, Tai H, Liu Y, Zhu Y. A high stroma-tumor ratio is associated with an immunosuppressive tumor microenvironment and a poor prognosis in bladder cancer. Front Oncol. 2025;15:1604609. https:\/\/doi.org\/10.3389\/fonc.2025.1604609. PMID: 40919138; PMCID: PMC12411155.","journal-title":"Front Oncol"},{"key":"4080_CR3","doi-asserted-by":"publisher","first-page":"121422","DOI":"10.1016\/j.biomaterials.2022.121422","volume":"283","author":"G Li","year":"2022","unstructured":"Li G, Tao T, Deng D, Zhang S, Chao Y, Dai Y, Li Y, Tao R, Yuan S, Liu Z, Wu S. Collagen-targeted tumor-specific transepithelial penetration enhancer mediated intravesical chemoimmunotherapy for non-muscle-invasive bladder cancer. Biomaterials. 2022;283:121422. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121422. Epub 2022 Feb 18. PMID: 35220019.","journal-title":"Biomaterials"},{"issue":"8","key":"4080_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41589-025-01841-3","volume":"21","author":"W Fu","year":"2025","unstructured":"Fu W, Wang J, Li T, Qiao Y, Zhang Z, Zhang X, He M, Su Y, Zhao Z, Li C, Xiao R, Han Y, Zhang S, Liu Z, Lin J, Chen G, Li Y, Zhong Q. Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol. 2025;21(8):1238\u201349. https:\/\/doi.org\/10.1038\/s41589-025-01841-3. Epub 2025 Feb 6. PMID: 39915626.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"4080_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/ijms23031465","volume":"23","author":"T Cs\u00edp\u0151","year":"2022","unstructured":"Cs\u00edp\u0151 T, Czikora \u00c1, F\u00fcl\u00f6p G\u00c1, Guly\u00e1s H, Rutkai I, T\u00f3th EP, P\u00f3rsz\u00e1sz R, Szalai A, B\u00f6lcskei K, Helyes Z, Pint\u00e9r E, Papp Z, Ungv\u00e1ri Z, T\u00f3th A. A central role for TRPM4 in Ca2+-Signal amplification and vasoconstriction. Int J Mol Sci. 2022;23(3):1465. https:\/\/doi.org\/10.3390\/ijms23031465. PMID: 35163382; PMCID: PMC8836177.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4080_CR6","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/1878-0261.12566","volume":"13","author":"S Kappel","year":"2019","unstructured":"Kappel S, Stok\u0142osa P, Hauert B, Ross-Kaschitza D, Borgstr\u00f6m A, Baur R, Galv\u00e1n JA, Zlobec I, Peinelt C. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells. Mol Oncol. 2019;13(11):2393\u2013405. Epub 2019 Sep 12. PMID: 31441200; PMCID: PMC6822246.","journal-title":"Mol Oncol"},{"issue":"1","key":"4080_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymthe.2022.08.016","volume":"31","author":"W Shi","year":"2023","unstructured":"Shi W, Lv L, Liu N, Wang H, Wang Y, Zhu W, Liu Z, Zhu J, Lu H. A novel anti-PD-L1\/IL-15 Immunocytokine overcomes resistance to PD-L1 Blockade and elicits potent antitumor immunity. Mol Ther. 2023;31(1):66\u201377. Epub 2022 Aug 30. PMID: 36045584; PMCID: PMC9840182.","journal-title":"Mol Ther"},{"key":"4080_CR8","doi-asserted-by":"publisher","first-page":"1225483","DOI":"10.3389\/fonc.2023.1225483","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Pan D, Huang X, Wang S, Chen H, Zhu YZ, Ye L. Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy. Front Oncol. 2023;13:1225483. https:\/\/doi.org\/10.3389\/fonc.2023.1225483. PMID: 37692860; PMCID: PMC10484796.","journal-title":"Front Oncol"},{"issue":"11","key":"4080_CR9","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1038\/s41388-021-01677-w","volume":"40","author":"K Cui","year":"2021","unstructured":"Cui K, Yao S, Zhang H, Zhou M, Liu B, Cao Y, Fei B, Huang S, Huang Z. Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer. Oncogene. 2021;40(11):2130\u201345. https:\/\/doi.org\/10.1038\/s41388-021-01677-w. Epub 2021 Feb 24. PMID: 33627780.","journal-title":"Oncogene"},{"issue":"24","key":"4080_CR10","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.3390\/ijms232415970","volume":"23","author":"H Chen","year":"2022","unstructured":"Chen H, Yang W, Xue X, Li Y, Jin Z, Ji Z. Integrated analysis revealed an inflammatory cancer-Associated Fibroblast-Based subtypes with promising implications in predicting the prognosis and immunotherapeutic response of bladder cancer patients. Int J Mol Sci. 2022;23(24):15970. https:\/\/doi.org\/10.3390\/ijms232415970. PMID: 36555612; PMCID: PMC9781727.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4080_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12672-025-01990-w","volume":"16","author":"X Huang","year":"2025","unstructured":"Huang X, Wang Y, Wang J, Jing Y, Dilraba E, Li Y, Guo C. Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer. Discov Oncol. 2025;16(1):218. https:\/\/doi.org\/10.1007\/s12672-025-01990-w. PMID: 39979699; PMCID: PMC11842647.","journal-title":"Discov Oncol"},{"issue":"7","key":"4080_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.21037\/tcr-23-34","volume":"12","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wang Y, Bi X, Ismtula D, Wang H, Guo C. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer. Transl Cancer Res. 2023;12(7):1765\u201386. https:\/\/doi.org\/10.21037\/tcr-23-34. Epub 2023 Jul 4. PMID: 37588751; PMCID: PMC10425657.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"4080_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12672-025-02032-1","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Wang Y, Jing Y, Zhu Y, Huang X, Wang J, Dilraba E, Guo C. Visualization analysis of breast cancer-related ubiquitination modifications over the past two decades. Discov Oncol. 2025;16(1):431. https:\/\/doi.org\/10.1007\/s12672-025-02032-1. PMID: 40163091; PMCID: PMC11958930.","journal-title":"Discov Oncol"},{"key":"4080_CR14","first-page":"755","volume":"17","author":"X Aimaiti","year":"2025","unstructured":"Aimaiti X, Wang Y, Ismtula D, Li Y, Ma H, Wang J, Elihamu D, Guo C. Bystin is a prognosis and immune biomarker: from Pan-Cancer analysis to validation in breast cancer. Breast Cancer (Dove Med Press). 2025;17:755\u201379. PMID: 40904351; PMCID: PMC12404263.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"4080_CR15","doi-asserted-by":"publisher","first-page":"110888","DOI":"10.1016\/j.cellsig.2023.110888","volume":"111","author":"Y Li","year":"2023","unstructured":"Li Y, Maimaiti M, Yang B, Lu Z, Zheng Q, Lin Y, Luo W, Wang R, Ding L, Wang H, Chen X, Xu Z, Wang M, Li G, Gao L. Comprehensive analysis of subtypes and risk model based on complement system associated genes in CcRCC. Cell Signal. 2023;111:110888. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110888. Epub 2023 Sep 16. PMID: 37717714.","journal-title":"Cell Signal"},{"key":"4080_CR16","doi-asserted-by":"publisher","first-page":"1099385","DOI":"10.3389\/fonc.2023.1099385","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Gao Z, Chen J, Feng S, Luo X, Shi Y, Tang Z, Liu W, Zhang X, Huang A, Gao Q, Ke A, Zhou J, Fan J, Fu X, Ding Z. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. Front Oncol. 2023;13:1099385. https:\/\/doi.org\/10.3389\/fonc.2023.1099385. PMID: 37593098; PMCID: PMC10430781.","journal-title":"Front Oncol"},{"issue":"2","key":"4080_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/cas.16400","volume":"116","author":"Q Wang","year":"2025","unstructured":"Wang Q, Zhong W, Xiao Y, Lin G, Lu J, Xu L, Zhang G, Liu A, Du J, Wu B. Pan-immune-inflammation value predicts immunotherapy response and reflects local antitumor immune response in rectal cancer. Cancer Sci. 2025;116(2):350\u201366. Epub 2024 Nov 27. PMID: 39601159; PMCID: PMC11786305.","journal-title":"Cancer Sci"},{"issue":"1","key":"4080_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00415-019-09584-7","volume":"267","author":"AH Erga","year":"2020","unstructured":"Erga AH, Alves G, Tysnes OB, Pedersen KF. Evolution of impulsive-compulsive behaviors and cognition in parkinson\u2019s disease. J Neurol. 2020;267(1):259\u201366. https:\/\/doi.org\/10.1007\/s00415-019-09584-7. Epub 2019 Oct 18. PMID: 31628533; PMCID: PMC6954890.","journal-title":"J Neurol"},{"issue":"7","key":"4080_CR19","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Yu A, Othmane B, Qiu D, Li H, Li C, Liu P, Ren W, Chen M, Gong G, Guo X, Zhang H, Chen J, Zu X. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics. 2021;11(7):3089\u2013108. https:\/\/doi.org\/10.7150\/thno.53649. PMID: 33537076; PMCID: PMC7847675.","journal-title":"Theranostics"},{"issue":"2","key":"4080_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/bioinformatics\/btab561","volume":"38","author":"S Wang","year":"2022","unstructured":"Wang S, Xiong Y, Zhao L, Gu K, Li Y, Zhao F, Li J, Wang M, Wang H, Tao Z, Wu T, Zheng Y, Li X, Liu XS. UCSCXenaShiny: an R\/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics. 2022;38(2):527\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btab561. PMID: 34323947; PMCID: PMC8723150.","journal-title":"Bioinformatics"},{"issue":"2","key":"4080_CR21","doi-asserted-by":"publisher","first-page":"102258","DOI":"10.1016\/j.xpro.2023.102258","volume":"4","author":"J Mei","year":"2023","unstructured":"Mei J, Cai Y, Xu R, Zhu Y, Zhao X, Zhang Y, Mao W, Xu J, Yin Y. Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers. STAR Protoc. 2023;4(2):102258. https:\/\/doi.org\/10.1016\/j.xpro.2023.102258. Epub ahead of print. PMID: 37119142; PMCID: PMC10173013.","journal-title":"STAR Protoc"},{"key":"4080_CR22","doi-asserted-by":"publisher","first-page":"1101055","DOI":"10.3389\/fonc.2023.1101055","volume":"13","author":"DX Li","year":"2023","unstructured":"Li DX, Feng DC, Shi X, Wu RC, Chen K, Han P. Identification of endothelial-related molecular subtypes for bladder cancer patients. Front Oncol. 2023;13:1101055. https:\/\/doi.org\/10.3389\/fonc.2023.1101055. PMID: 37025597; PMCID: PMC10070733.","journal-title":"Front Oncol"},{"key":"4080_CR23","doi-asserted-by":"publisher","unstructured":"Ke H, Zhu L, Wang Q, Xu K. Exploring the therapeutic potential of PACAP in Hunner-type Interstitial Cystitis. World J Urol. 2025;43(1):60. https:\/\/doi.org\/10.1007\/s00345-024-05429-9.","DOI":"10.1007\/s00345-024-05429-9"},{"key":"4080_CR24","doi-asserted-by":"publisher","first-page":"105152","DOI":"10.1016\/j.ebiom.2024.105152","volume":"104","author":"L Liu","year":"2024","unstructured":"Liu L, Xu L, Wu D, Zhu Y, Li X, Xu C, Chen K, Lin Y, Lao J, Cai P, Li X, Luo Y, Li X, Huang J, Lin T, Zhong W. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. EBioMedicine. 2024;104:105152. Epub 2024 May 9. PMID: 38728838; PMCID: PMC11090066.","journal-title":"EBioMedicine"},{"key":"4080_CR25","doi-asserted-by":"publisher","first-page":"576911","DOI":"10.3389\/fonc.2021.576911","volume":"11","author":"Y Shi","year":"2022","unstructured":"Shi Y, Chen S, Xing H, Jiang G, Wu N, Liu Q, Sakamoto N, Kuno T, Sugiura R, Xiao Q, Jin F, Fang Y, Yao F. Comprehensive analysis of prognostic Microenvironment-Related genes in invasive breast cancer. Front Oncol. 2022;11:576911. PMID: 35047378; PMCID: PMC8761742.","journal-title":"Front Oncol"},{"issue":"1","key":"4080_CR26","doi-asserted-by":"publisher","first-page":"e2103836","DOI":"10.1002\/advs.202103836","volume":"9","author":"S Peng","year":"2022","unstructured":"Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive nanomedicine for enhanced cancer immunotherapy. Adv Sci (Weinh). 2022;9(1):e2103836. https:\/\/doi.org\/10.1002\/advs.202103836. Epub 2021 Nov 19. PMID: 34796689; PMCID: PMC8728817.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4080_CR27","doi-asserted-by":"publisher","first-page":"17460","DOI":"10.1038\/s41598-024-68111-5","volume":"14","author":"D Wu","year":"2024","unstructured":"Wu D, Liu Y, Liu J, Ma L, Tong X. Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma. Sci Rep. 2024;14(1):17460. https:\/\/doi.org\/10.1038\/s41598-024-68111-5. PMID: 39075165; PMCID: PMC11286868.","journal-title":"Sci Rep"},{"issue":"1","key":"4080_CR28","doi-asserted-by":"publisher","first-page":"2439539","DOI":"10.1080\/07853890.2024.2439539","volume":"57","author":"C Zhang","year":"2025","unstructured":"Zhang C, Wang Y, Yu Y, Pang Y, Xiao X, Hao L. Overexpression of ST8Sia1 inhibits tumor progression by TGF-\u03b21 signaling in rectal adenocarcinoma and promotes the tumoricidal effects of CD8+ T cells by granzyme B and Perforin. Ann Med. 2025;57(1):2439539. Epub 2024 Dec 10. PMID: 39656552; PMCID: PMC11633436.","journal-title":"Ann Med"},{"key":"4080_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.amjcard.2025.07.025","volume":"256","author":"GL Wilkie","year":"2025","unstructured":"Wilkie GL, Patel R, Kovell L, Whelan A. Maternal cardiac and perinatal outcomes among pregnant individuals with ebstein\u2019s anomaly. Am J Cardiol. 2025;256:45\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2025.07.025. Epub ahead of print. PMID: 40712819; PMCID: PMC12331151.","journal-title":"Am J Cardiol"},{"issue":"6","key":"4080_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00262-017-2058-z","volume":"67","author":"F Petitprez","year":"2018","unstructured":"Petitprez F, Vano YA, Becht E, Giraldo NA, de Reyni\u00e8s A, Saut\u00e8s-Fridman C, Fridman WH. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. Cancer Immunol Immunother. 2018;67(6):981\u20138. https:\/\/doi.org\/10.1007\/s00262-017-2058-z. Epub 2017 Sep 7. PMID: 28884365; PMCID: PMC11028160.","journal-title":"Cancer Immunol Immunother"},{"key":"4080_CR31","doi-asserted-by":"publisher","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, Krogsdam A, Loncova Z, Posch W, Wilflingseder D, Sopper S, Ijsselsteijn M, Brouwer TP, Johnson D, Xu Y, Wang Y, Sanders ME, Estrada MV, Ericsson-Gonzalez P, Charoentong P, Balko J, de Miranda NFDCC, Trajanoski Z. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34. https:\/\/doi.org\/10.1186\/s13073-019-0638-6. Erratum in: Genome Med. 2019;11(1):50. https:\/\/doi.org\/10.1186\/s13073-019-0655-5.","DOI":"10.1186\/s13073-019-0638-6"},{"key":"4080_CR32","doi-asserted-by":"publisher","unstructured":"Chen X, Zhang S, Zhang L, Yao Z, Chen X, Zheng Y, Liu Y. Applications and theory of electrokinetic enrichment in micro-nanofluidic chips. Biomed Microdevices. 2017;19(3):19. https:\/\/doi.org\/10.1007\/s10544-017-0168-1.","DOI":"10.1007\/s10544-017-0168-1"},{"key":"4080_CR33","doi-asserted-by":"publisher","unstructured":"Yu N, Zhao Y, Wang P, Zhang F, Wen C, Wang S. Changes in border-associated macrophages after stroke: Single-cell sequencing analysis. Neural Regen Res. 2026;21(1):346\u2013356. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01092.","DOI":"10.4103\/NRR.NRR-D-24-01092"},{"issue":"1","key":"4080_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12885-023-11761-x","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Han T, Miao R, Zhou J, Guo J, Xu Z, Xing Y, Bai Y, Wu J, Hu D. RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness. BMC Cancer. 2024;24(1):7. https:\/\/doi.org\/10.1186\/s12885-023-11761-x. PMID: 38167018; PMCID: PMC10763365.","journal-title":"BMC Cancer"},{"key":"4080_CR35","doi-asserted-by":"publisher","first-page":"1000321","DOI":"10.3389\/fimmu.2022.1000321","volume":"13","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, Cai Z, Deng D, Tong S, Zu X. An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer. Front Immunol. 2022;13:1000321. https:\/\/doi.org\/10.3389\/fimmu.2022.1000321. PMID: 36211349; PMCID: PMC9540509.","journal-title":"Front Immunol"},{"key":"4080_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7."},{"key":"4080_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70045","author":"X Dai","year":"2025","unstructured":"Dai X, Wang M, Liu Y. A Hiplot-based web service for cold atmospheric plasma high-throughput data integration and analysis on breast cancer. Imeta. 2025;4(4):e70045. https:\/\/doi.org\/10.1002\/imt2.70045."},{"issue":"5","key":"4080_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/10543406.2022.2162070","volume":"33","author":"HA Newer","year":"2023","unstructured":"Newer HA. The weighted log-rank tests based on stratified clustered survival data: saddle-point p-values and confidence intervals. J Biopharm Stat. 2023;33(5):544\u201354. Epub 2022 Dec 28. PMID: 36578189.","journal-title":"J Biopharm Stat"},{"issue":"5","key":"4080_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.gpb.2023.05.001","volume":"21","author":"Y Pan","year":"2023","unstructured":"Pan Y, Li R, Li W, Lv L, Guan J, Zhou S. HPC-Atlas: computationally constructing A comprehensive atlas of human protein complexes. Genomics Proteom Bioinf. 2023;21(5):976\u201390. https:\/\/doi.org\/10.1016\/j.gpb.2023.05.001. Epub 2023 Sep 18. PMID: 37730114; PMCID: PMC10928439.","journal-title":"Genomics Proteom Bioinf"},{"issue":"1","key":"4080_CR40","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, Han X. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6. PMID: 35145098; PMCID: PMC8831564.","journal-title":"Nat Commun"},{"key":"4080_CR41","doi-asserted-by":"publisher","first-page":"712354","DOI":"10.3389\/fphar.2021.712354","volume":"12","author":"P Arullampalam","year":"2021","unstructured":"Arullampalam P, Preti B, Ross-Kaschitza D, Lochner M, Rougier JS, Abriel H. Species-Specific effects of cation channel TRPM4 Small-Molecule inhibitors. Front Pharmacol. 2021;12:712354. https:\/\/doi.org\/10.3389\/fphar.2021.712354. PMID: 34335274; PMCID: PMC8321095.","journal-title":"Front Pharmacol"},{"issue":"18","key":"4080_CR42","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1158\/0008-5472.CAN-23-0157","volume":"83","author":"S Ghosh","year":"2023","unstructured":"Ghosh S, Yang R, Duraki D, Zhu J, Kim JE, Jabeen M, Mao C, Dai X, Livezey MR, Boudreau MW, Park BH, Nelson ER, Hergenrother PJ, Shapiro DJ. Plasma membrane channel TRPM4 mediates Immunogenic Therapy-Induced necrosis. Cancer Res. 2023;83(18):3115\u201330. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0157. PMID: 37522838; PMCID: PMC10635591.","journal-title":"Cancer Res"},{"issue":"1","key":"4080_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12885-023-10576-0","volume":"23","author":"M Jung","year":"2023","unstructured":"Jung M, Rose M, Knuechel R, Loeffler C, Muti H, Kather JN, Gaisa NT. German study group of bladder cancer (DFBK e.V.). Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer. BMC Cancer. 2023;23(1):113. https:\/\/doi.org\/10.1186\/s12885-023-10576-0. PMID: 36726072; PMCID: PMC9890720.","journal-title":"BMC Cancer"},{"key":"4080_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-020-1116-3","volume":"20","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Xiong Z, Cao H, Li C, Wanggou S, Li X. Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures. Cancer Cell Int. 2020;20:37. https:\/\/doi.org\/10.1186\/s12935-020-1116-3. PMID: 32021566; PMCID: PMC6995093.","journal-title":"Cancer Cell Int"},{"issue":"23","key":"4080_CR45","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom F, Ramirez-Valdez RA, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, Fussell S, Tobin KKS, Dutertre CA, Lynn GM, M\u00fcller S, Ginhoux F, Ishizuka AS, Seder RA. Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment. Cell. 2022;185(23):4317\u2013e433215. https:\/\/doi.org\/10.1016\/j.cell.2022.10.006. Epub 2022 Oct 26. PMID: 36302380; PMCID: PMC9669246.","journal-title":"Cell"},{"key":"4080_CR46","doi-asserted-by":"publisher","unstructured":"Liu Y, Yu Y, Chen Y, Zhuang J, Sun C. Tumor Immunosenescence driven by chronic inflammation: mechanisms, microenvironment remodeling and therapeutic strategies. Aging Dis. 2025;15. https:\/\/doi.org\/10.14336\/AD.2025.0471.","DOI":"10.14336\/AD.2025.0471"},{"key":"4080_CR47","doi-asserted-by":"publisher","first-page":"1151632","DOI":"10.3389\/fimmu.2023.1151632","volume":"14","author":"AE Brunell","year":"2023","unstructured":"Brunell AE, Lahesmaa R, Autio A, Thotakura AK. Exhausted T cells hijacking the cancer-immunity cycle: assets and liabilities. Front Immunol. 2023;14:1151632. https:\/\/doi.org\/10.3389\/fimmu.2023.1151632. PMID: 37122741; PMCID: PMC10140554.","journal-title":"Front Immunol"},{"issue":"10","key":"4080_CR48","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1172\/JCI127046","volume":"129","author":"M Fakih","year":"2019","unstructured":"Fakih M, Ouyang C, Wang C, Tu TY, Gozo MC, Cho M, Sy M, Longmate JA, Lee PP. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. J Clin Invest. 2019;129(10):4464\u201376. PMID: 31524634; PMCID: PMC6763253.","journal-title":"J Clin Invest"},{"issue":"7","key":"4080_CR49","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21(7):1688\u201398. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0432. Epub 2014 Sep 10. PMID: 25208879; PMCID: PMC4362882.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4080_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccell.2024.12.002","volume":"43","author":"K Ellrott","year":"2025","unstructured":"Ellrott K, Wong CK, Yau C, Castro MAA, Lee JA, Karlberg BJ, Grewal JK, Lagani V, Tercan B, Friedl V, Hinoue T, Uzunangelov V, Westlake L, Loinaz X, Felau I, Wang PI, Kemal A, Caesar-Johnson SJ, Shmulevich I, Lazar AJ, Tsamardinos I, Hoadley KA, Robertson AG, Knijnenburg TA, Benz CC, Stuart JM, Zenklusen JC, Cherniack AD, Laird PW. Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets. Cancer Cell. 2025;43(2):195\u2013e21211. Epub 2025 Jan 2. PMID: 39753139; PMCID: PMC11949768.","journal-title":"Cancer Cell"},{"issue":"5","key":"4080_CR51","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.33809","volume":"150","author":"C Olah","year":"2022","unstructured":"Olah C, Hahnen C, Nagy N, Musial J, Varadi M, Nyiro G, Gyorffy B, Hadaschik B, Rawitzer J, Ting S, Sj\u00f6dahl G, Hoffmann MJ, Reis H, Szarvas T. A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes. Int J Cancer. 2022;150(5):856\u201367. https:\/\/doi.org\/10.1002\/ijc.33809. Epub 2021 Oct 2. PMID: 34536301.","journal-title":"Int J Cancer"},{"issue":"1","key":"4080_CR52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12881-019-0936-2","volume":"20","author":"Y Li","year":"2019","unstructured":"Li Y, Bian Y, Wang K, Wan XP. POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF\/AMFR signal transduction. BMC Med Genet. 2019;20(1):202. https:\/\/doi.org\/10.1186\/s12881-019-0936-2. PMID: 31864301; PMCID: PMC6925869.","journal-title":"BMC Med Genet"},{"key":"4080_CR53","doi-asserted-by":"publisher","unstructured":"Yao J, Liu Y, Yang J, Li M, Li S, Zhang B, Yang R, Zhang Y, Cui X, Feng C. Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells. Front Genet., Yao J, Liu Y, Yang J, Li M, Li S, Zhang B, Yang R, Zhang Y, Cui X, Feng C. Single-cell sequencing reveals that dbi is the key gene and potential therapeutic target in quiescent bladder cancer stem cells. Front Genet. 2022;13:904536. https:\/\/doi.org\/10.3389\/fgene.2022.904536.","DOI":"10.3389\/fgene.2022.904536"},{"issue":"17","key":"4080_CR54","doi-asserted-by":"publisher","first-page":"e36599","DOI":"10.1016\/j.heliyon.2024.e36599","volume":"10","author":"X Jin","year":"2024","unstructured":"Jin X, Hu Z, Yin J, Shan G, Zhao M, Liao Z, Liang J, Bi G, Cheng Y, Xi J, Chen Z, Lin M. Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1. Heliyon. 2024;10(17):e36599. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36599. PMID: 39263115; PMCID: PMC11388764.","journal-title":"Heliyon"},{"issue":"9","key":"4080_CR55","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/ijms18091959","volume":"18","author":"S Byun","year":"2017","unstructured":"Byun S, Lee E, Lee KW. Therapeutic implications of autophagy inducers in immunological Disorders, Infection, and cancer. Int J Mol Sci. 2017;18(9):1959. https:\/\/doi.org\/10.3390\/ijms18091959. PMID: 28895911; PMCID: PMC5618608.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4080_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.bjc.6604098","volume":"98","author":"A Dey","year":"2008","unstructured":"Dey A, Verma CS, Lane DP. Updates on p53: modulation of p53 degradation as a therapeutic approach. Br J Cancer. 2008;98(1):4\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6604098. Epub 2008 Jan 8. PMID: 18182973; PMCID: PMC2359710.","journal-title":"Br J Cancer"},{"issue":"1","key":"4080_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/cvr\/cvad158","volume":"120","author":"F Rolski","year":"2024","unstructured":"Rolski F, Tkacz K, W\u0119glarczyk K, Kwiatkowski G, Pelczar P, Ja\u017awa-Kusior A, Bar A, Kuster GM, Ch\u0142opicki S, Siedlar M, Kania G, B\u0142yszczuk P. TNF-\u03b1 protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4\u2009+\u2009T cells. Cardiovasc Res. 2024;120(1):82\u201394. https:\/\/doi.org\/10.1093\/cvr\/cvad158. PMID: 37879102; PMCID: PMC10898940.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"4080_CR58","first-page":"2325","volume":"8","author":"S Inoue","year":"2018","unstructured":"Inoue S, Ide H, Mizushima T, Jiang G, Kawahara T, Miyamoto H. ELK1 promotes urothelial tumorigenesis in the presence of an activated androgen receptor. Am J Cancer Res. 2018;8(11):2325\u201336. PMID: 30555747; PMCID: PMC6291651.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"4080_CR59","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1128\/JCM.02153-16","volume":"55","author":"AG L\u2019Huillier","year":"2017","unstructured":"L\u2019Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB. Evaluation of Altona diagnostics RealStar Zika virus reverse Transcription-PCR test kit for Zika virus PCR testing. J Clin Microbiol. 2017;55(5):1576\u201384. Epub 2017 Mar 15. PMID: 28298448; PMCID: PMC5405276.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4080_CR60","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms23095097","volume":"23","author":"MT Sung","year":"2022","unstructured":"Sung MT, Wang YH, Li CF. Open the technical black box of tumor mutational burden (TMB): factors affecting harmonization and standardization of Panel-Based TMB. Int J Mol Sci. 2022;23(9):5097. https:\/\/doi.org\/10.3390\/ijms23095097. PMID: 35563486; PMCID: PMC9103036.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4080_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/ph15010081","volume":"15","author":"ZM Kov\u00e1cs","year":"2022","unstructured":"Kov\u00e1cs ZM, Dienes C, H\u00e9zs\u0151 T, Alm\u00e1ssy J, Magyar J, B\u00e1ny\u00e1sz T, N\u00e1n\u00e1si PP, Horv\u00e1th B, Szentandr\u00e1ssy N. Pharmacological modulation and (Patho)Physiological roles of TRPM4 Channel-Part 1: modulation of TRPM4. Pharmaceuticals (Basel). 2022;15(1):81. https:\/\/doi.org\/10.3390\/ph15010081. PMID: 35056138; PMCID: PMC8781449.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"4080_CR62","doi-asserted-by":"publisher","first-page":"e012069","DOI":"10.1136\/jitc-2025-012069","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, Zhou Z, Zhang L, Luo P, Zhang Z. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(7):e012069. https:\/\/doi.org\/10.1136\/jitc-2025-012069. PMID: 40744665; PMCID: PMC12315039.","journal-title":"J Immunother Cancer"},{"key":"4080_CR63","doi-asserted-by":"crossref","unstructured":"Zhang H, Xu GZP, Yu F, Li L, Huang R, Zhang P, Kadier K, Wang Y, Gu Q, Ding Y, Gu T, Chi H, Zhang S, Wu R, Xu Y, Zhu S, Zheng H, Zhao T, He Q, Qiu X. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res Homepage. 2025;1(1).","DOI":"10.1002\/mdr2.70004"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04080-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:47:12Z","timestamp":1767026832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04080-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04080-z","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2105-14-7","asserted-by":"subject"},{"id-type":"doi","id":"10.1002\/imt2.70045","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized publicly available, de-identified datasets. The original collection of these data was conducted in accordance with relevant ethical guidelines and received appropriate ethical approval (including informed consent from participants) by the original investigators. As this secondary analysis involves no new data collection or interaction with human subjects, and uses only anonymized data, additional ethical approval for this specific analysis was not required. All analyses were performed in compliance with the terms of use of the respective datasets. As a result, the ethics, consent to participate, and consent to publish declarations is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2257"}}